HCW Biologics (HCWB) Competitors $6.90 -1.04 (-13.10%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$7.10 +0.19 (+2.83%) As of 04/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HCWB vs. VERA, SPRY, IRON, MESO, IMCR, TVTX, INDV, OCUL, EWTX, and CALTShould you be buying HCW Biologics stock or one of its competitors? The main competitors of HCW Biologics include Vera Therapeutics (VERA), ARS Pharmaceuticals (SPRY), Disc Medicine (IRON), Mesoblast (MESO), Immunocore (IMCR), Travere Therapeutics (TVTX), Indivior (INDV), Ocular Therapeutix (OCUL), Edgewise Therapeutics (EWTX), and Calliditas Therapeutics AB (publ) (CALT). These companies are all part of the "pharmaceutical products" industry. HCW Biologics vs. Vera Therapeutics ARS Pharmaceuticals Disc Medicine Mesoblast Immunocore Travere Therapeutics Indivior Ocular Therapeutix Edgewise Therapeutics Calliditas Therapeutics AB (publ) HCW Biologics (NASDAQ:HCWB) and Vera Therapeutics (NASDAQ:VERA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, community ranking, analyst recommendations, valuation, media sentiment and institutional ownership. Which has stronger valuation and earnings, HCWB or VERA? HCW Biologics has higher revenue and earnings than Vera Therapeutics. Vera Therapeutics is trading at a lower price-to-earnings ratio than HCW Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHCW Biologics$2.57M3.02-$24.99M-$31.20-0.22Vera TherapeuticsN/AN/A-$95.99M-$2.75-8.44 Does the media prefer HCWB or VERA? In the previous week, Vera Therapeutics had 4 more articles in the media than HCW Biologics. MarketBeat recorded 7 mentions for Vera Therapeutics and 3 mentions for HCW Biologics. Vera Therapeutics' average media sentiment score of 1.21 beat HCW Biologics' score of 0.72 indicating that Vera Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HCW Biologics 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Vera Therapeutics 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of HCWB or VERA? 3.0% of HCW Biologics shares are owned by institutional investors. Comparatively, 99.2% of Vera Therapeutics shares are owned by institutional investors. 49.9% of HCW Biologics shares are owned by insiders. Comparatively, 16.3% of Vera Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts prefer HCWB or VERA? Vera Therapeutics has a consensus price target of $64.67, indicating a potential upside of 178.50%. Given Vera Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Vera Therapeutics is more favorable than HCW Biologics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HCW Biologics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Vera Therapeutics 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 3 Strong Buy rating(s) 3.20 Does the MarketBeat Community prefer HCWB or VERA? Vera Therapeutics received 35 more outperform votes than HCW Biologics when rated by MarketBeat users. However, 100.00% of users gave HCW Biologics an outperform vote while only 66.13% of users gave Vera Therapeutics an outperform vote. CompanyUnderperformOutperformHCW BiologicsOutperform Votes6100.00% Underperform VotesNo VotesVera TherapeuticsOutperform Votes4166.13% Underperform Votes2133.87% Which has more risk and volatility, HCWB or VERA? HCW Biologics has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500. Comparatively, Vera Therapeutics has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Is HCWB or VERA more profitable? Vera Therapeutics has a net margin of 0.00% compared to HCW Biologics' net margin of -1,067.82%. Vera Therapeutics' return on equity of -50.13% beat HCW Biologics' return on equity.Company Net Margins Return on Equity Return on Assets HCW Biologics-1,067.82% -2,516.84% -132.95% Vera Therapeutics N/A -50.13%-39.50% SummaryVera Therapeutics beats HCW Biologics on 13 of the 18 factors compared between the two stocks. Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCWB vs. The Competition Export to ExcelMetricHCW BiologicsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.75M$6.70B$5.47B$7.82BDividend YieldN/A3.17%5.43%4.30%P/E Ratio-6.907.2022.3518.43Price / Sales3.02239.17391.12101.46Price / CashN/A65.8538.1834.62Price / Book18.656.306.684.19Net Income-$24.99M$142.95M$3.22B$248.05M7 Day Performance-2.13%8.00%6.24%6.53%1 Month Performance-42.92%-4.16%-2.81%-2.16%1 Year Performance-87.68%-2.77%16.46%4.71% HCW Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCWBHCW Biologics1.0612 of 5 stars$6.90-13.1%N/A-88.2%$7.75M$2.57M-6.9040Short Interest ↓Gap DownVERAVera Therapeutics2.7223 of 5 stars$21.50-4.1%$64.67+200.8%-40.0%$1.43BN/A-8.2440Options VolumeNews CoveragePositive NewsSPRYARS Pharmaceuticals3.146 of 5 stars$14.47+3.0%$31.00+114.2%+70.2%$1.42B$89.15M-28.3790Positive NewsIRONDisc Medicine2.1703 of 5 stars$40.27+4.0%$93.80+132.9%+71.3%$1.39BN/A-10.1230News CoveragePositive NewsMESOMesoblast2.0138 of 5 stars$10.74+5.9%$18.00+67.6%+92.2%$1.36B$5.67M0.0080Positive NewsGap UpIMCRImmunocore3.0439 of 5 stars$26.92+1.2%$63.73+136.7%-48.0%$1.33B$310.20M-28.34320News CoveragePositive NewsTVTXTravere Therapeutics2.8708 of 5 stars$14.83+2.3%$32.08+116.3%+240.1%$1.32B$233.18M-3.62460Upcoming EarningsAnalyst ForecastNews CoveragePositive NewsINDVIndivior3.8696 of 5 stars$9.44+3.6%$15.00+58.9%-33.0%$1.30B$1.19B-26.971,164Earnings ReportShort Interest ↑Analyst RevisionNews CoveragePositive NewsOCULOcular Therapeutix3.3124 of 5 stars$7.57+6.5%$16.38+116.3%+83.6%$1.20B$63.72M-5.73230News CoverageEWTXEdgewise Therapeutics2.327 of 5 stars$12.33+8.0%$40.38+227.5%-6.9%$1.20BN/A-8.2260Short Interest ↑Positive NewsCALTCalliditas Therapeutics AB (publ)N/A$40.00flat$39.25-1.9%N/A$1.19B$1.60B-21.62180 Related Companies and Tools Related Companies Vera Therapeutics Competitors ARS Pharmaceuticals Competitors Disc Medicine Competitors Mesoblast Competitors Immunocore Competitors Travere Therapeutics Competitors Indivior Competitors Ocular Therapeutix Competitors Edgewise Therapeutics Competitors Calliditas Therapeutics AB (publ) Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCWB) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
